Windows of opportunity for Ebola virus infection treatment and vaccination
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Windows of opportunity for Ebola virus infection treatment and vaccination
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-15
DOI
10.1038/s41598-017-08884-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
- (2017) D Gray Heppner et al. LANCET INFECTIOUS DISEASES
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
- (2017) Christine Dahlke et al. EBioMedicine
- A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines
- (2017) Thomas Richardson et al. PLoS One
- Ebola virus vaccines: Where do we stand?
- (2016) Vincent Pavot CLINICAL IMMUNOLOGY
- Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
- (2016) Vincent Madelain et al. CLINICAL PHARMACOKINETICS
- Ebola virus disease candidate vaccines under evaluation in clinical trials
- (2016) Karen A. Martins et al. Expert Review of Vaccines
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
- (2016) Surender Khurana et al. NATURE MEDICINE
- Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature
- (2016) Camelia Nami Saber et al. ORAL ONCOLOGY
- Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation
- (2016) Takamitsu Hattori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection
- (2016) Stefanie Duvigneau et al. Scientific Reports
- Post-treatment control of HIV infection
- (2015) Jessica M. Conway et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Modeling Influenza Virus Infection: A Roadmap for Influenza Research
- (2015) Alessandro Boianelli et al. Viruses-Basel
- Ebola virus infection modeling and identifiability problems
- (2015) Van Kinh Nguyen et al. Frontiers in Microbiology
- A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making
- (2015) Maria D. Van Kerkhove et al. Scientific Data
- Effects of Aging on Influenza Virus Infection Dynamics
- (2014) E. A. Hernandez-Vargas et al. JOURNAL OF VIROLOGY
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Optimal therapy scheduling for a simplified HIV infection model
- (2013) Esteban A. Hernandez-Vargas et al. AUTOMATICA
- Switching Strategies to Mitigate HIV Mutation
- (2013) IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY
- Analytical Sensitivity of Seven Point-of-Care Influenza Virus Detection Tests and Two Molecular Tests for Detection of Avian Origin H7N9 and Swine Origin H3N2 Variant Influenza A Viruses
- (2013) K.-H. Chan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead
- (2011) Catherine AA Beauchemin et al. BMC PUBLIC HEALTH
- Computer simulation of structured treatment interruption for HIV infection
- (2011) Jorge Ferreira et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Aging and impaired immunity to influenza viruses: Implications for vaccine development
- (2011) Wai Ming Liu et al. Human vaccines & immunotherapeutics
- Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection
- (2011) A. Haas et al. JOURNAL OF VIROLOGY
- Influenza A virus infection kinetics: quantitative data and models
- (2011) Amber M. Smith et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Nonhuman Primate Models of Human Immunology
- (2010) Ilhem Messaoudi et al. ANTIOXIDANTS & REDOX SIGNALING
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- Long-term HIV dynamics subject to continuous therapy and structured treatment interruptions
- (2008) Marios M. Hadjiandreou et al. CHEMICAL ENGINEERING SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started